MARICHU NICHOLS: Open Payments
NPI 1760103006 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $296 · 2025 $486
Food & beverage: $386Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $125 |
| Janssen Biotech, Inc. | 1 | $122 |
| Regeneron Healthcare Solutions, Inc. | 1 | $111 |
| Iovance Biotherapeutics, Inc. | 1 | $36 |
| Lilly USA, LLC | 2 | $35 |
| PharmaEssentia USA Corporation | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $24 |
Products named: RYBREVANT, LYNOZYFIC, Amtagvi, VERZENIO, BESREMI, Jakafi, KEYTRUDA.
Industry payments across VA — which companies pay providers there.
